• mail us help@24marketresearch.com
  • Int'l (+1)-646-781-7170
  • UK(Toll free) +44-800-088-5734

TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media

Global Major Depressive Disorder Market Size, Status and Forecast 2018-2025

Global Major Depressive Disorder Market Size, Status and Forecast 2018-2025

  • Category:Life Sciences
  • Published on : 29 August 2018
  • Pages :96
  • Formats:
  • Report Code:24MRES-3055710
Click for best price

Best Price: $3120

This report focuses on the global Major Depressive Disorder status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Major Depressive Disorder development in United States, Europe and China.

Major depressive disorder, also known as major depression and clinical depression, is a mental disorder characterized by loss of interest and pleasure in enjoyable environment. People are affected in different ways by major depression. Some people have trouble sleeping, feel agitated and irritable, and have sudden weight loss. Moreover, they can have other mental and physical symptoms such as fatigue, memory loss, feeling of hopelessness, body aches, headaches, and thoughts of suicide.
In terms of geography, North America dominates the global major depressive disorder market due to increased awareness about various depression conditions in the region. The U.S. represents the largest market for major depressive disorder in North America, followed by Canada. In Europe, Germany, France, the U.K., Italy, and Spain account for a major share of the major depressive disorder market. This market in Asia is expected to expand at a significant rate over the next five years. This is due to various companies setting up manufacturing facilities in the region. Moreover, increasing awareness about various depression episodes and rise in geriatric population are also driving the growth of the market in the region. India, China, and Japan are expected to be the fastest growing major depressive disorder markets in Asia.
In 2017, the global Major Depressive Disorder market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2018-2025.

The key players covered in this study
Pfizer
Eli Lilly
H. Lundbeck
Otsuka Pharmaceutical
AstraZeneca
Alkermes
Takeda Pharmaceutical
Naurex
Euthymics Bioscience
E-therapeutics

Market segment by Type, the product can be split into
Drugs Therapy
Biological Therapy
Meditation
Physiotherapy
Other

Market segment by Application, split into
Under 25 Years Old
25-45 Years Old
Above 45 Years Old

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Major Depressive Disorder status, future forecast, growth opportunity, key market and key players.
To present the Major Depressive Disorder development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Major Depressive Disorder are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

TABLE OF CONTENTS

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Major Depressive Disorder Market Size Growth Rate by Type (2013-2025)
1.4.2 Drugs Therapy
1.4.3 Biological Therapy
1.4.4 Meditation
1.4.5 Physiotherapy
1.4.6 Other
1.5 Market by Application
1.5.1 Global Major Depressive Disorder Market Share by Application (2013-2025)
1.5.2 Under 25 Years Old
1.5.3 25-45 Years Old
1.5.4 Above 45 Years Old
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Major Depressive Disorder Market Size
2.2 Major Depressive Disorder Growth Trends by Regions
2.2.1 Major Depressive Disorder Market Size by Regions (2013-2025)
2.2.2 Major Depressive Disorder Market Share by Regions (2013-2018)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Major Depressive Disorder Market Size by Manufacturers
3.1.1 Global Major Depressive Disorder Revenue by Manufacturers (2013-2018)
3.1.2 Global Major Depressive Disorder Revenue Market Share by Manufacturers (2013-2018)
3.1.3 Global Major Depressive Disorder Market Concentration Ratio (CR5 and HHI)
3.2 Major Depressive Disorder Key Players Head office and Area Served
3.3 Key Players Major Depressive Disorder Product/Solution/Service
3.4 Date of Enter into Major Depressive Disorder Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Major Depressive Disorder Market Size by Type (2013-2018)
4.2 Global Major Depressive Disorder Market Size by Application (2013-2018)

5 United States
5.1 United States Major Depressive Disorder Market Size (2013-2018)
5.2 Major Depressive Disorder Key Players in United States
5.3 United States Major Depressive Disorder Market Size by Type
5.4 United States Major Depressive Disorder Market Size by Application

6 Europe
6.1 Europe Major Depressive Disorder Market Size (2013-2018)
6.2 Major Depressive Disorder Key Players in Europe
6.3 Europe Major Depressive Disorder Market Size by Type
6.4 Europe Major Depressive Disorder Market Size by Application

7 China
7.1 China Major Depressive Disorder Market Size (2013-2018)
7.2 Major Depressive Disorder Key Players in China
7.3 China Major Depressive Disorder Market Size by Type
7.4 China Major Depressive Disorder Market Size by Application

8 Japan
8.1 Japan Major Depressive Disorder Market Size (2013-2018)
8.2 Major Depressive Disorder Key Players in Japan
8.3 Japan Major Depressive Disorder Market Size by Type
8.4 Japan Major Depressive Disorder Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Major Depressive Disorder Market Size (2013-2018)
9.2 Major Depressive Disorder Key Players in Southeast Asia
9.3 Southeast Asia Major Depressive Disorder Market Size by Type
9.4 Southeast Asia Major Depressive Disorder Market Size by Application

10 India
10.1 India Major Depressive Disorder Market Size (2013-2018)
10.2 Major Depressive Disorder Key Players in India
10.3 India Major Depressive Disorder Market Size by Type
10.4 India Major Depressive Disorder Market Size by Application

11 Central & South America
11.1 Central & South America Major Depressive Disorder Market Size (2013-2018)
11.2 Major Depressive Disorder Key Players in Central & South America
11.3 Central & South America Major Depressive Disorder Market Size by Type
11.4 Central & South America Major Depressive Disorder Market Size by Application

12 International Players Profiles
12.1 Pfizer
12.1.1 Pfizer Company Details
12.1.2 Company Description and Business Overview
12.1.3 Major Depressive Disorder Introduction
12.1.4 Pfizer Revenue in Major Depressive Disorder Business (2013-2018)
12.1.5 Pfizer Recent Development
12.2 Eli Lilly
12.2.1 Eli Lilly Company Details
12.2.2 Company Description and Business Overview
12.2.3 Major Depressive Disorder Introduction
12.2.4 Eli Lilly Revenue in Major Depressive Disorder Business (2013-2018)
12.2.5 Eli Lilly Recent Development
12.3 H. Lundbeck
12.3.1 H. Lundbeck Company Details
12.3.2 Company Description and Business Overview
12.3.3 Major Depressive Disorder Introduction
12.3.4 H. Lundbeck Revenue in Major Depressive Disorder Business (2013-2018)
12.3.5 H. Lundbeck Recent Development
12.4 Otsuka Pharmaceutical
12.4.1 Otsuka Pharmaceutical Company Details
12.4.2 Company Description and Business Overview
12.4.3 Major Depressive Disorder Introduction
12.4.4 Otsuka Pharmaceutical Revenue in Major Depressive Disorder Business (2013-2018)
12.4.5 Otsuka Pharmaceutical Recent Development
12.5 AstraZeneca
12.5.1 AstraZeneca Company Details
12.5.2 Company Description and Business Overview
12.5.3 Major Depressive Disorder Introduction
12.5.4 AstraZeneca Revenue in Major Depressive Disorder Business (2013-2018)
12.5.5 AstraZeneca Recent Development
12.6 Alkermes
12.6.1 Alkermes Company Details
12.6.2 Company Description and Business Overview
12.6.3 Major Depressive Disorder Introduction
12.6.4 Alkermes Revenue in Major Depressive Disorder Business (2013-2018)
12.6.5 Alkermes Recent Development
12.7 Takeda Pharmaceutical
12.7.1 Takeda Pharmaceutical Company Details
12.7.2 Company Description and Business Overview
12.7.3 Major Depressive Disorder Introduction
12.7.4 Takeda Pharmaceutical Revenue in Major Depressive Disorder Business (2013-2018)
12.7.5 Takeda Pharmaceutical Recent Development
12.8 Naurex
12.8.1 Naurex Company Details
12.8.2 Company Description and Business Overview
12.8.3 Major Depressive Disorder Introduction
12.8.4 Naurex Revenue in Major Depressive Disorder Business (2013-2018)
12.8.5 Naurex Recent Development
12.9 Euthymics Bioscience
12.9.1 Euthymics Bioscience Company Details
12.9.2 Company Description and Business Overview
12.9.3 Major Depressive Disorder Introduction
12.9.4 Euthymics Bioscience Revenue in Major Depressive Disorder Business (2013-2018)
12.9.5 Euthymics Bioscience Recent Development
12.10 E-therapeutics
12.10.1 E-therapeutics Company Details
12.10.2 Company Description and Business Overview
12.10.3 Major Depressive Disorder Introduction
12.10.4 E-therapeutics Revenue in Major Depressive Disorder Business (2013-2018)
12.10.5 E-therapeutics Recent Development

13 Market Forecast 2018-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2018-2025)
13.10 Market Size Forecast by Application (2018-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

LIST OF TABLES & FIGURES

List of Tables and Figures

Table Major Depressive Disorder Key Market Segments
Table Key Players Major Depressive Disorder Covered
Table Global Major Depressive Disorder Market Size Growth Rate by Type 2013-2025 (Million US$)
Figure Global Major Depressive Disorder Market Size Market Share by Type 2013-2025
Figure Drugs Therapy Figures
Table Key Players of Drugs Therapy
Figure Biological Therapy Figures
Table Key Players of Biological Therapy
Figure Meditation Figures
Table Key Players of Meditation
Figure Physiotherapy Figures
Table Key Players of Physiotherapy
Figure Other Figures
Table Key Players of Other
Table Global Major Depressive Disorder Market Size Growth by Application 2013-2025 (Million US$)
Figure Under 25 Years Old Case Studies
Figure 25-45 Years Old Case Studies
Figure Above 45 Years Old Case Studies
Figure Major Depressive Disorder Report Years Considered
Table Global Major Depressive Disorder Market Size 2013-2025 (Million US$)
Figure Global Major Depressive Disorder Market Size and Growth Rate 2013-2025 (Million US$)
Table Global Major Depressive Disorder Market Size by Regions 2013-2025 (Million US$)
Table Global Major Depressive Disorder Market Size by Regions 2013-2018 (Million US$)
Table Global Major Depressive Disorder Market Share by Regions 2013-2018
Figure Global Major Depressive Disorder Market Share by Regions 2013-2018
Figure Global Major Depressive Disorder Market Share by Regions 2018
Table Market Top Trends
Table Global Major Depressive Disorder Revenue by Manufacturers (2013-2018) (Million US$)
Table Global Major Depressive Disorder Market Share by Manufacturers (2013-2018)
Figure Global Major Depressive Disorder Market Share by Manufacturers in 2018
Table Global Major Depressive Disorder Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Major Depressive Disorder Product/Solution/Service
Table Date of Enter into Major Depressive Disorder Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Major Depressive Disorder Market Size by Type (2013-2018) (Million US$)
Table Global Major Depressive Disorder Market Size Share by Type (2013-2018)
Figure Global Major Depressive Disorder Market Size Market Share by Type (2013-2018)
Table Global Major Depressive Disorder Market Size by Application (2013-2018) (Million US$)
Table Global Major Depressive Disorder Market Size Share by Application (2013-2018)
Figure Global Major Depressive Disorder Market Size Market Share by Application (2013-2018)
Figure Global Major Depressive Disorder Revenue Market Share by Application in 2017
Figure United States Major Depressive Disorder Market Size 2013-2018 (Million US$)
Table United States Key Players Major Depressive Disorder Revenue (2017-2018) (Million US$)
Table United States Key Players Major Depressive Disorder Market Share (2017-2018)
Table United States Major Depressive Disorder Market Size by Type (2013-2018) (Million US$)
Table United States Major Depressive Disorder Market Share by Type (2013-2018)
Table United States Major Depressive Disorder Market Size by Application (2013-2018) (Million US$)
Table United States Major Depressive Disorder Market Share by Application (2013-2018)
Figure Europe Major Depressive Disorder Market Size 2013-2018 (Million US$)
Table Europe Key Players Major Depressive Disorder Revenue (2017-2018) (Million US$)
Table Europe Key Players Major Depressive Disorder Market Share (2017-2018)
Table Europe Major Depressive Disorder Market Size by Type (2013-2018) (Million US$)
Table Europe Major Depressive Disorder Market Share by Type (2013-2018)
Table Europe Major Depressive Disorder Market Size by Application (2013-2018) (Million US$)
Table Europe Major Depressive Disorder Market Share by Application (2013-2018)
Figure China Major Depressive Disorder Market Size 2013-2018 (Million US$)
Table China Key Players Major Depressive Disorder Revenue (2017-2018) (Million US$)
Table China Key Players Major Depressive Disorder Market Share (2017-2018)
Table China Major Depressive Disorder Market Size by Type (2013-2018) (Million US$)
Table China Major Depressive Disorder Market Share by Type (2013-2018)
Table China Major Depressive Disorder Market Size by Application (2013-2018) (Million US$)
Table China Major Depressive Disorder Market Share by Application (2013-2018)
Figure Japan Major Depressive Disorder Market Size 2013-2018 (Million US$)
Table Japan Key Players Major Depressive Disorder Revenue (2017-2018) (Million US$)
Table Japan Key Players Major Depressive Disorder Market Share (2017-2018)
Table Japan Major Depressive Disorder Market Size by Type (2013-2018) (Million US$)
Table Japan Major Depressive Disorder Market Share by Type (2013-2018)
Table Japan Major Depressive Disorder Market Size by Application (2013-2018) (Million US$)
Table Japan Major Depressive Disorder Market Share by Application (2013-2018)
Figure Southeast Asia Major Depressive Disorder Market Size 2013-2018 (Million US$)
Table Southeast Asia Key Players Major Depressive Disorder Revenue (2017-2018) (Million US$)
Table Southeast Asia Key Players Major Depressive Disorder Market Share (2017-2018)
Table Southeast Asia Major Depressive Disorder Market Size by Type (2013-2018) (Million US$)
Table Southeast Asia Major Depressive Disorder Market Share by Type (2013-2018)
Table Southeast Asia Major Depressive Disorder Market Size by Application (2013-2018) (Million US$)
Table Southeast Asia Major Depressive Disorder Market Share by Application (2013-2018)
Figure India Major Depressive Disorder Market Size 2013-2018 (Million US$)
Table India Key Players Major Depressive Disorder Revenue (2017-2018) (Million US$)
Table India Key Players Major Depressive Disorder Market Share (2017-2018)
Table India Major Depressive Disorder Market Size by Type (2013-2018) (Million US$)
Table India Major Depressive Disorder Market Share by Type (2013-2018)
Table India Major Depressive Disorder Market Size by Application (2013-2018) (Million US$)
Table India Major Depressive Disorder Market Share by Application (2013-2018)
Figure Central & South America Major Depressive Disorder Market Size 2013-2018 (Million US$)
Table Central & South America Key Players Major Depressive Disorder Revenue (2017-2018) (Million US$)
Table Central & South America Key Players Major Depressive Disorder Market Share (2017-2018)
Table Central & South America Major Depressive Disorder Market Size by Type (2013-2018) (Million US$)
Table Central & South America Major Depressive Disorder Market Share by Type (2013-2018)
Table Central & South America Major Depressive Disorder Market Size by Application (2013-2018) (Million US$)
Table Central & South America Major Depressive Disorder Market Share by Application (2013-2018)
Table Pfizer Company Details
Table Pfizer Revenue in Major Depressive Disorder Business (2013-2018) (Million US$)
Figure Pfizer Revenue Growth Rate in Major Depressive Disorder Business (2013-2018)
Table Pfizer Recent Development
Table Eli Lilly Company Details
Table Eli Lilly Revenue in Major Depressive Disorder Business (2013-2018)(Million US$)
Figure Eli Lilly Revenue Growth Rate in Major Depressive Disorder Business (2013-2018)
Table Eli Lilly Recent Development
Table H. Lundbeck Company Details
Table H. Lundbeck Revenue in Major Depressive Disorder Business (2013-2018)(Million US$)
Figure H. Lundbeck Revenue Growth Rate in Major Depressive Disorder Business (2013-2018)
Table H. Lundbeck Recent Development
Table Otsuka Pharmaceutical Company Details
Table Otsuka Pharmaceutical Revenue in Major Depressive Disorder Business (2013-2018)(Million US$)
Figure Otsuka Pharmaceutical Revenue Growth Rate in Major Depressive Disorder Business (2013-2018)
Table Otsuka Pharmaceutical Recent Development
Table AstraZeneca Company Details
Table AstraZeneca Revenue in Major Depressive Disorder Business (2013-2018)(Million US$)
Figure AstraZeneca Revenue Growth Rate in Major Depressive Disorder Business (2013-2018)
Table AstraZeneca Recent Development
Table Alkermes Company Details
Table Alkermes Revenue in Major Depressive Disorder Business (2013-2018)(Million US$)
Figure Alkermes Revenue Growth Rate in Major Depressive Disorder Business (2013-2018)
Table Alkermes Recent Development
Table Takeda Pharmaceutical Company Details
Table Takeda Pharmaceutical Revenue in Major Depressive Disorder Business (2013-2018)(Million US$)
Figure Takeda Pharmaceutical Revenue Growth Rate in Major Depressive Disorder Business (2013-2018)
Table Takeda Pharmaceutical Recent Development
Table Naurex Company Details
Table Naurex Revenue in Major Depressive Disorder Business (2013-2018)(Million US$)
Figure Naurex Revenue Growth Rate in Major Depressive Disorder Business (2013-2018)
Table Naurex Recent Development
Table Euthymics Bioscience Company Details
Table Euthymics Bioscience Revenue in Major Depressive Disorder Business (2013-2018)(Million US$)
Figure Euthymics Bioscience Revenue Growth Rate in Major Depressive Disorder Business (2013-2018)
Table Euthymics Bioscience Recent Development
Table E-therapeutics Company Details
Table E-therapeutics Revenue in Major Depressive Disorder Business (2013-2018)(Million US$)
Figure E-therapeutics Revenue Growth Rate in Major Depressive Disorder Business (2013-2018)
Table E-therapeutics Recent Development
Table Global Major Depressive Disorder Market Size by Regions (Million US$) 2018-2025
Figure Global Major Depressive Disorder Market Size Share by Regions (2018-2025)
Figure Global Major Depressive Disorder Market Size Share by Regions in 2025
Figure United States Major Depressive Disorder Market Size Forecast (2018-2025)(Million USD)
Figure Europe Major Depressive Disorder Market Size Forecast (2018-2025)(Million USD)
Figure China Major Depressive Disorder Market Size Forecast (2018-2025)(Million USD)
Figure Japan Major Depressive Disorder Market Size Forecast (2018-2025)(Million USD)
Figure Southeast Asia Major Depressive Disorder Market Size Forecast (2018-2025)(Million USD)
Figure India Major Depressive Disorder Market Size Forecast (2018-2025)(Million USD)
Figure Central & South America Major Depressive Disorder Market Size Forecast (2018-2025)(Million USD)
Table Global Major Depressive Disorder Market Size by Product (2018-2025) (Million US$)
Figure Global Major Depressive Disorder Market Size by Product (2018-2025)
Figure Global Major Depressive Disorder Market Size by Product in 2025
Table Global Major Depressive Disorder Market Size by Application (2018-2025) (Million US$)
Figure Global Major Depressive Disorder Market Size by Application (2018-2025)
Figure Global Major Depressive Disorder Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

SELECT A FORMAT

USD GBP EURO YEN Single User Price
USD GBP EURO YEN Enterprise Price

---- OR ----

Frequently Asked Questions ?

  • Upto 24 hrs - Working days
  • Upto 48 hrs max - Weekends and public holidays
  • Single User License
    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License
    A license granted to multiple users.

  • Site License
    A license granted to a single business site/establishment.

  • Corporate License, Global License
    A license granted to all employees within organisation access to the product.
  • Online Payments with PayPal and CCavenue
  • Wire Transfer/Bank Transfer
  • Email
  • Hard Copy
check discount
  BENCHMARKS  
Loading Time: Base Classes  0.1273
Controller Execution Time ( Reports Controller / Report Details )  1.0120
Total Execution Time  1.1422
  GET DATA  
No GET data exists
  MEMORY USAGE  
1,215,664 bytes
  POST DATA  
No POST data exists
  URI STRING  
life-sciences/3055710/global-major-depressive-disorder-2018-2025-212
  CLASS/METHOD  
Reports_controller/report_details
  DATABASE:  chemical_common24 (Reports_controller:$db)   QUERIES: 12 (0.9723 seconds)  (Hide)
0.0001   SELECT GET_LOCK('ee714358aae8203823496a2640ee5bc0'300) AS ci_session_lock 
0.3431   SELECT `data`
FROM `24mresearch_ci_sessions`
WHERE `id` = '54f07666641e7389323351368fd6536051a76b70' 
0.0252   SELECT `24_report`.*, `24_sub_cat_1`.`sc1_name`, `24_sub_cat_1`.`sc1_url`, `24_sub_cat_1`.`sc1_status`, `24_publisher`.`publisher_name`, `24_report_metadata`.*
FROM `24_report`
LEFT JOIN `24_sub_cat_1ON `24_sub_cat_1`.`sc1_id` = `24_report`.`rep_sub_cat_1_id`
LEFT JOIN `24_publisherON `24_publisher`.`publisher_id` = `24_report`.`publisher_id`
LEFT JOIN `24_report_metadataON `24_report_metadata`.`meta_rep_id` = `24_report`.`rep_id`
WHERE `rep_status` = 'Y'
AND `rep_archive_status` = 'N'
AND `rep_date` > '2017-03-31'
AND `24_report`.`rep_id` = '3055710' 
0.0002   SELECT `sc1_id`, `sc1_url`, `sc1_name`
FROM `24_sub_cat_1`
WHERE `sc1_status` = 'Y'
ORDER BY `sc1_idAS
0.0002   SELECT *
FROM `24_report_license`
WHERE `li_rep_id` = '3055710'
AND `li_pub_id` = '1' 
0.6028   SELECT `24_report`.`rep_title`, `24_report`.`rep_id`, `24_report`.`rep_url`, `24_report`.`rep_date`, `24_sub_cat_1`.`sc1_url`, `24_sub_cat_1`.`sc1_name`
FROM `24_report`
LEFT JOIN `24_sub_cat_1ON `24_report`.`rep_sub_cat_1_id`=`24_sub_cat_1`.`sc1_id`
WHERE `rep_status` = 'Y'
AND `rep_archive_status` = 'N'
AND `rep_date` > '2017-03-31'
AND  `rep_titleLIKE '%major depressive disorder%' ESCAPE '!'
 
LIMIT 4 
0.0002   SELECT FROM 24_report_currency WHERE cur_symbol 'GBP' 
0.0001   SELECT FROM 24_report_currency WHERE cur_symbol 'EUR' 
0.0001   SELECT FROM 24_report_currency WHERE cur_symbol 'JPY' 
0.0001   SELECT FROM 24_report_currency WHERE cur_symbol 'GBP' 
0.0001   SELECT FROM 24_report_currency WHERE cur_symbol 'EUR' 
0.0001   SELECT FROM 24_report_currency WHERE cur_symbol 'JPY' 
  HTTP HEADERS  (Show)
  SESSION DATA  (Show)
  CONFIG VARIABLES  (Show)